Plus therapeutics shareholder update: transition achieved in 2019; poised for expansion in 2020

Austin, texas, jan. 06, 2020 (globe newswire) -- plus therapeutics, inc. (nasdaq: pstv ) (the “company”) today issued the following letter to shareholders from dr. marc hedrick, president and chief executive officer.

PSTV Ratings Summary

PSTV Quant Ranking